Koninklijke Philips (NYSE:PHG – Get Free Report) was upgraded by analysts at Jefferies Financial Group from an “underperform” rating to a “hold” rating in a research note issued on Tuesday, MarketBeat Ratings reports.
Separately, StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Monday, July 15th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold”.
Koninklijke Philips Stock Down 1.9 %
Koninklijke Philips (NYSE:PHG – Get Free Report) last announced its quarterly earnings data on Monday, July 29th. The technology company reported $0.32 earnings per share for the quarter. The company had revenue of $4.80 billion for the quarter. Koninklijke Philips had a positive return on equity of 10.15% and a negative net margin of 2.35%. As a group, research analysts anticipate that Koninklijke Philips will post 1.59 EPS for the current year.
Hedge Funds Weigh In On Koninklijke Philips
Several hedge funds have recently bought and sold shares of PHG. Allspring Global Investments Holdings LLC acquired a new position in shares of Koninklijke Philips in the first quarter valued at approximately $40,000. Fairscale Capital LLC acquired a new position in Koninklijke Philips in the 2nd quarter valued at $54,000. Eastern Bank acquired a new position in Koninklijke Philips in the 3rd quarter valued at $88,000. CWM LLC lifted its stake in shares of Koninklijke Philips by 21.9% during the 2nd quarter. CWM LLC now owns 3,429 shares of the technology company’s stock worth $86,000 after purchasing an additional 616 shares during the period. Finally, Blue Trust Inc. boosted its holdings in shares of Koninklijke Philips by 902.7% during the second quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock worth $93,000 after purchasing an additional 3,331 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- What is the S&P 500 and How It is Distinct from Other Indexes
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How to Invest in the Best Canadian StocksĀ
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.